English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Karyopharm Therapeutics (KPTI.US)$ Reuters· 5 mins ago
Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 Sentry Trial in Myelofibrosis
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
3939 Views
Comment
Sign in to post a comment